Heritage Global Partners (“HGP”), a subsidiary of Heritage Global Inc. (NASDAQ: HGBL) and a worldwide leader in asset ...
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and ...
Cure Rare Disease (CRD), a non-profit biotechnology organization, today announced a landmark partnership with the LGMD2L ...
TORONTO, ON / ACCESS Newswire / March 2, 2026 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") ...
TURKU, FI / ACCESS Newswire / March 2, 2026 / Faron Pharmaceuticals Ltd (HEL:FARON)(LSE:FARN), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, ...
The global nutraceuticals market, valued at approximately USD 416 billion in 2026, is projected to grow at a CAGR of around 9 ...
LCS commercial launch is ongoing in U.S. following FDA 510(k) clearanceCE-marking regulatory process is on-going with a ...
Demonstrating the power of adaptive design, NGHS and TLD Group celebrate six years of leadership growth across the health system. NEW YORK CITY, NY / ACCESS Newswire / March 2, 2026 / The Leadership ...
Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed ...
Grants to Strengthen Prevention Models and Local Systems of Care Nationwide –FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead ...
T® from the pivotal Precision-T Phase 3 study will be presented including quality of life and rates of rehospitalizations compared to conventional alloHSCTData evaluating the use of Orca-T with ...
PVP Labs, a biotechnology pioneer specializing in peptide-based drug development, today announced its selection to present at ...